Biomark Capital provides venture funding and assistance to early, mid, and late-stage life science companies.
Biomark Capital provides venture funding and assistance to early, mid, and late-stage life science companies. We target companies with novel approaches to diagnostics, therapeutics, medical devices, and digital health that will change the face of healthcare innovation in the future. We share the drive and vision of our portfolio companies to collaborate with them in accelerating growth and building successful business ventures.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Feb 13, 2012
ADMA Biologics
|
Series Unknown | $17.50M | Biotechnology | — |